Page 2 - Element Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Major companies operating in the global cross laminated timber (CLT) market, which include Stora Enso (Finland), Binderholz GmbH (Austria), KLH Massivholz...

Cannabis abuse linked with increased morbidity among spine surgery patients ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You've successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Cannabis a...

Personalized vaccine shows potential benefit across cancer types Source: Marron TU, et al. Abstract LB048. Presented at: American Association for Cancer Research Annual Meeting (virtual meeting); April 10-15, 2021. Disclosures: Marron reports advisory or data safety monitoring board roles with AstraZeneca, Atara Biotherapeutics, Boehringer Ingelheim, Celldex Therapeutics, Genentech and Regeneron, and research support from Bristol Myers Squibb, Boehringer Ingelheim and Regeneron. See the abstract for all other researchers’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive...

Blue Cross and Blue Shield of Minnesota announced it will partner with DaVita Inc. to launch its integrated kidney care VillageHealth program in the Blue Cross Minnesota network. According to a press release, VillageHealth will allow Blue Cross members with chronic kidney disease or end-stage kidney disease to seek earlier and better care at a reduced cost. The new program promises improved

B-cell depletion with rituximab was safe and may be a potentially effective treatment for patients with systemic sclerosis-associated pulmonary arterial hypertension, researchers reported. “This is the first placebo-controlled trial of a B-cell depleting therapy for PAH. While a negative study, the results were suggestive of therapeutic value. Selective immunotherapy, possibly guided by